Vitamin D Receptor Agonists for Hemodialysis Patients, Titin Los-of-Function Variants and Atrial Fibrillation, COIs as Research Misconduct, and more
Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the December 11, 2018 issue